Two senior managers resign to pursue opportunities outside AstraZeneca Pharma India

Management Changes View source PDF Explain this filing

ASTRAZEN · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+2.9%Reaction day

₹8480.00

prior close

₹8726.00

announcement price

In-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used-1.1%+4.0% vs market

Pharmaceuticals peers, median of 164sector-0.7%+3.6% vs sector

On the reaction day the stock moved 4.0 pts more than Nifty Microcap 250 and 3.6 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+0.1

10m

+0.1

15m

+0.2

30m

+0.3

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+2.9-1.1+4.0-0.7+3.6

Next day

+2.2-0.0+2.2-1.0+3.1

+0.3+0.2+0.1-1.0+1.3

+0.7+1.1-0.4-0.9+1.6

+1.6+1.1+0.5-0.9+2.4

-0.7-0.9+0.2-1.6+0.9

-1.9-0.5-1.3-1.2-0.7

15d

+1.1+7.1-5.9+2.9-1.8

-3.0+6.5-9.5+4.0-6.9

-2.1+7.9-10.0+5.0-7.1

-18.5+11.2-29.7+6.0-24.6

UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 164Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

AstraZeneca Pharma India has informed the stock exchanges about the resignation of two senior managers. Mr. Ayush Kumar Agarwal, Business Unit Director for the Biopharmaceutical Business Unit, will leave on June 12, 2026. Ms. Shikha Mirchandani Chatrath, Director of Commercial Excellence, BD and Strategy, will leave on August 3, 2026. Both are leaving to pursue career opportunities outside the company. The company is looking for replacements.

Likely market impact

Loss of two senior leaders in biopharma and strategy may cause short-term transition issues while replacements are sought.